A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

Locally advanced or metastatic urothelial cancer is an aggressive form of cancer with high recurrence rates and low survival. Nectin-4 is a cell adhesion molecule commonly expressed in several tumors, including high expression in urothelial cancer. Enfortumab vedotin is an antibody–drug conjugate co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Invest New Drugs
Päätekijät: Takahashi, Shunji, Uemura, Motohide, Kimura, Tomokazu, Kawasaki, Yoshihide, Takamoto, Atsushi, Yamaguchi, Akito, Melhem-Bertrandt, Amal, Gartner, Elaina M., Inoue, Takashi, Akazawa, Rio, Kadokura, Takeshi, Tanikawa, Toshiki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2019
Aiheet:
Phase I Studies
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340645/
https://ncbi.nlm.nih.gov/pubmed/31444589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00844-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia